| 物质名称 | BEVACIZUMAB |
|---|---|
| 异名/同义词 | IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER LY 01008 LY 01008 [WHO-DD] LY 01008(BIOSIMILAR OF BEVACIZUMAB) LY-01008 MB02 MB-02 MVASI OYAVAS PF-06439535 PF-06439535 [WHO-DD] Q1101 Q-1101 QL-1101 (BIOSIMILAR OF BEVACIZUMAB) RG-435 RHUMAB- RO-4876646 USP MAB 002, MONOCLONAL IGG1 [USP-RS] VEGZELMA ZIRABEV BAT 1706 [WHO-DD] BAT1706 BAT-1706 BAT-1706 (BIOSIMILAR OF BEVACIZUMAB) BEVACIZUMAB BEVACIZUMAB (AVASTIN) BEVACIZUMAB [EMA EPAR] BEVACIZUMAB [INN] BEVACIZUMAB [JAN] BEVACIZUMAB [MART.] BEVACIZUMAB [MI] BEVACIZUMAB [PURPLE BOOK CDER] BEVACIZUMAB [USAN] BEVACIZUMAB [VANDF] BEVACIZUMAB [WHO-DD] BEVACIZUMAB AWWB [WHO-DD] BEVACIZUMAB BETA BEVACIZUMAB BETA [INN] BEVACIZUMAB BETA [WHO-DD] BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH BEVACIZUMAB BIOSIMILAR (ABP-215) BEVACIZUMAB BIOSIMILAR (AMGEN) BEVACIZUMAB BIOSIMILAR (AMNEAL PHARMACEUTICALS) BEVACIZUMAB BIOSIMILAR (CT-P16) BEVACIZUMAB BIOSIMILAR (FKB-238) BEVACIZUMAB BIOSIMILAR (GP-2019) BEVACIZUMAB BIOSIMILAR (MABXIENCE) BEVACIZUMAB BIOSIMILAR (PF-06439535) BEVACIZUMAB BIOSIMILAR (PFIZER) BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS BEVACIZUMAB BVZR [WHO-DD] BEVACIZUMAB MALY [WHO-DD] BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED BEVACIZUMAB-ADCD BEVACIZUMAB-AWWB BEVACIZUMAB-AWWB [PURPLE BOOK CDER] BEVACIZUMAB-BVZR BEVACIZUMAB-MALY BEVACIZUMAB-TNJN BEVAX BEVZ92 BEVZ-92 BI 695502 [WHO-DD] BI695502 BI-695502 BS-503 BS-503A BYVASDA CT P16 [WHO-DD] CT16 CT-16 CTP16 CTP-16 CT-P16 CT-P16 (BIOSIMILAR OF BEVACIZUMAB) FKB 238 [WHO-DD] FKB238 FKB-238 GP2019 GP-2019 HLX 04 [WHO-DD] HLX04 HLX-04 IBI305 IBI-305 12-IGG1 ABP-215 ALYMSYS AVA-1 AVASTIN AVZIVI |
| CAS登记号 | 216974-75-3 |
| 物质唯一标识(Unique Ingredient Identifier) | 2S9ZZM9Q9V |
| 分子式 | |
| 国际化合物标识(International Chemical Identifier,InChI) | |
| SMILES | |
| 分子结构式 | |
| 欧洲化学品管理局注册号(ECHA) | |
| 成分类型 | INGREDIENT SUBSTANCE / protein |
| 关联数据 |
|
| 扩展资源 |